Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NutriTechLab is an academic spin-off of the University of Naples Federico II, founded in July 2024 and based at the CEINGE Advanced Biotechnologies Research Center. The company specializes in developing innovative immunonutrition solutions, postbiotics, and food supplements designed to prevent and treat allergic diseases, gastrointestinal disorders, and malnutrition, particularly in pediatric populations. NutriTechLab leverages advanced biotechnological processes, such as sequential fermentation of probiotic strains (e.g., Lacticaseibacillus rhamnosus GG and Lacticaseibacillus paracasei NPB-01), to create high-performance postbiotics (iPB) that enhance gut epithelial barrier integrity and stimulate innate immunity. The company's research-backed portfolio includes clinical-stage candidates targeting cow's milk allergy, pediatric acute rhinitis, and skin health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NutriTechLab.